GOLDMAN SACHS GROUP INC - NAVIDEA BIOPHARMACEUTICALS I ownership

NAVIDEA BIOPHARMACEUTICALS I's ticker is NAVBXXXX and the CUSIP is 63937X103. A total of 81 filers reported holding NAVIDEA BIOPHARMACEUTICALS I in Q3 2015. The put-call ratio across all filers is 2,040.10 and the average weighting 1.1%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of NAVIDEA BIOPHARMACEUTICALS I
ValueSharesWeighting
Q3 2018$31,0000.0%134,014
+0.1%
0.00%
Q2 2018$31,000
-35.4%
133,915
+0.1%
0.00%
Q1 2018$48,0000.0%133,741
+0.2%
0.00%
Q4 2017$48,000
-56.0%
133,517
-49.1%
0.00%
Q3 2017$109,000
-28.3%
262,066
-12.2%
0.00%
Q2 2017$152,000
-24.0%
298,595
-13.8%
0.00%
Q1 2017$200,000
-61.6%
346,311
-57.6%
0.00%
Q4 2016$521,000
-44.3%
816,726
-20.1%
0.00%
Q3 2016$936,000
-58.8%
1,022,514
-76.1%
0.00%
-100.0%
Q2 2016$2,273,000
-33.3%
4,283,942
+18.7%
0.00%0.0%
Q1 2016$3,409,000
-34.2%
3,609,934
-7.4%
0.00%
-50.0%
Q4 2015$5,184,000
-42.6%
3,897,939
-1.6%
0.00%
-33.3%
Q3 2015$9,032,000
+33.5%
3,961,211
-5.7%
0.00%
+50.0%
Q2 2015$6,765,000
+32.3%
4,201,871
+30.6%
0.00%0.0%
Q1 2015$5,115,000
+2789.8%
3,216,779
+3337.0%
0.00%
Q4 2014$177,000
+580.8%
93,592
+367.0%
0.00%
Q3 2014$26,000
-57.4%
20,041
-51.2%
0.00%
Q2 2014$61,000
-57.6%
41,050
-47.2%
0.00%
Q1 2014$144,000
+5.1%
77,684
+17.4%
0.00%
Q4 2013$137,000
+10.5%
66,181
+41.8%
0.00%
Q3 2013$124,000
-47.5%
46,676
-47.1%
0.00%
Q2 2013$236,000
+85.8%
88,272
+97.2%
0.00%
Q4 2012$127,000
-11.8%
44,774
-14.6%
0.00%
Q3 2012$144,000
-11.7%
52,405
+19.8%
0.00%
Q2 2012$163,000
+10.9%
43,762
-2.6%
0.00%
Q1 2012$147,00044,9510.00%
Other shareholders
NAVIDEA BIOPHARMACEUTICALS I shareholders Q3 2015
NameSharesValueWeighting ↓
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of NAVIDEA BIOPHARMACEUTICALS I shareholders